[Hemolysis influence on twenty-two biochemical parameters measurement]
Damien Ali1, Emilie Sacchetto1, Erwan Dumontet1
1Laboratoire de biochimie, Centre hospitalier universitaire de Nantes, Hôpital Guillaume et René Laënnec, Saint-Herblain, France.
Annales De Biologie Clinique
|May 31, 2014
Summary
Hemolysis significantly impacts 22 biochemical parameters, with some results overestimated or underestimated. Understanding these interferences is crucial for accurate clinical reporting of hemolyzed samples.
Area of Science:
- Clinical Biochemistry
- Analytical Chemistry
Context:
- Hemolysis is a common pre-analytical issue in clinical laboratories.
- Accurate biochemical analysis is vital for patient diagnosis and treatment.
Purpose:
- To experimentally determine the influence of hemolysis on 22 biochemical parameters using the Cobas 6000 analyzer.
- To classify parameters based on the direction and magnitude of hemolytic interference.
Summary:
- Hemolysis was induced by adding hemolysate to achieve hemoglobin concentrations from 0 to 2000 μmol/L.
- Parameters were categorized as unaffected, overestimated (e.g., AST, CK), or underestimated (e.g., ALT, GGT).
- Interference varied with analyte concentration, sometimes appearing in normal but not pathological values, or vice versa.
Impact:
- Provides essential data for clinical biologists to interpret results from hemolyzed samples.
- Highlights the need for method-specific validation of hemolysis interference.
- Contributes to improving the reliability of laboratory diagnostics in the presence of hemolysis.
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
382
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
382
01:20Measurement of Bioavailability: Pharmacodynamic Methods
1.0K
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
1.0K